Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Chugai Pharmaceutical Incorporates Wearable Devices Into Clinical Trials

Filed Under: Innovation, Pharma Tagged With: , , , , , , , , ,

Chugai Pharmaceutical Co. Ltd. (TYO:4519) has begun using wearable devices in its clinical development of new drugs. In one experiment,…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Coronavirus Report – Part 27: Pandemic Sees Clinical Trials for New Drugs Suspended, Postponed
Coronavirus Report – Part 27: Pandemic Sees Clinical Trials…
LSII to Launch Clinical Trials of Muse Cells to Treat Respiratory Failure in COVID-19 Patients
LSII to Launch Clinical Trials of Muse Cells to Treat…
Coronavirus Report – Part 67: Pandemic Causes 75% Drop in Clinical Trials for Early April
Coronavirus Report – Part 67: Pandemic Causes 75% Drop in…
Coronavirus Report – Part 13: Japanese Companies Start to Develop Vaccines, Treatments
Coronavirus Report – Part 13: Japanese Companies Start to…
Coronavirus Report – Part 77: Japan’s Pharmaceutical Companies Move in Quick Order to Treat Infection
Coronavirus Report – Part 77: Japan’s Pharmaceutical…
Coronavirus Report – Part 33: Japan Eyes Development of Five Potential Treatments
Coronavirus Report – Part 33: Japan Eyes Development of Five…